World Leading Stem Cell Product Provider Releases Its 500th Cord Blood Stem Cell Shipment For Transplant世界領先的幹細胞產品供應商發布其第五百臍血幹細胞移植的裝運
StemCyte, Inc., a privately-held stem cell therapy and cord blood company, with highly accredited processing and storage facilities in both the US and Taiwan, recently released its 500th cord blood stem cell shipment for transplant.移植StemCyte ,公司是一家私人持有的幹細胞療法和臍帶血公司,具有高度認可的處理和儲存設施,無論是美國和台灣,最近公佈其第五百臍血幹細胞移植的裝運。
This marks another milestone in the company’s rapid growth as one of the world’s leading providers of quality cord blood stem cell products.這標誌著另一個里程碑,在該公司的快速增長,作為世界上的領先供應商的質量臍帶血幹細胞產品。 StemCyte has now provided cord blood stem cell shipments to over 130 transplant centers worldwide across 6 continents, with the number of移植StemCyte現在已提供臍血幹細胞出貨量將超過130個移植中心,世界各地的跨越6大洲,與人數
shipments released for transplantation increasing rapidly.釋放出貨量為移植的人數迅速增加。 StemCyte’s therapeutic products have been used for the treatment of over 40 diseases, including leukemias, lymphomas, immune diseases and genetic disorders.移植StemCyte的治療產品已用於治療超過40的疾病,包括白血病,淋巴瘤,免疫性疾病和遺傳性疾病。
To find out more visit StemCyte online at http://www.stemcyte.com.找出更多訪問移植StemCyte在線上http://www.stemcyte.com 。
CONTACT:聯繫方式:
David Carmel朱迦密
StemCyte, Inc.移植StemCyte ,公司
917-414-4121
SOURCE StemCyte, Inc.來源移植StemCyte ,公司
Filed under提起下 Cord Blood Banking臍帶血銀行 , , Stem Cell幹細胞 | |
































